IMS
VC Fund
Milano, Italy
IMS is a VC fund in Milano focused on Life Science and Biotechnology. is an independent contract research organization
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries IMS invests in
Stages IMS invests in
Countries IMS invests in
Investment Focus
Industry
- Life Science 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BrainDTech
|
early diagnosis and monitoring of neurological and neurodegenerative diseases in liquid biopsies, based on miRNA from microglial microvesicles. | $567.1K / Series B / Dec 04, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does IMS invest in?
IMS invests primarily in Life Science, Biotechnology and Medical Device startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Italy. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did IMS last invest?
The most recent investment recorded for IMS closed in Dec 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
